CHEBI:73280 - sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate ChEBI ID CHEBI:73280 Definition An organic sodium salt having 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate as the counterion. Stars This entity has been manually annotated by the ChEBI Team. Submitter Margaret Duesbury Margaret Duesbury Secondary ChEBI IDs CHEBI:73486 Supplier Information Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C18H15N2NaO4 Net Charge 0 Average Mass 346.31250 Monoisotopic Mass 346.09295 InChI InChI=1S/C18H16N2O4.Na/c1-10-15(20-8-4-3-5-14(20)17(10)24-2)16(21)11-6-7-13(19)12(9-11)18(22)23;/h3-9H,19H2,1-2H3,(H,22,23);/q;+1/p-1 InChIKey JFBMSTWZURKQOC-UHFFFAOYSA-M SMILES [Na+].COc1c(C)c(C(=O)c2ccc(N)c(c2)C([O-])=O)n2ccccc12 Roles Classification Biological Role(s): fibroblast growth factor receptor antagonist An antagonist at the fibroblast growth factor receptor. Application(s): antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. View more via ChEBI Ontology ChEBI Ontology Outgoing sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has part 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73308) sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has role antineoplastic agent (CHEBI:35610) sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has role fibroblast growth factor receptor antagonist (CHEBI:63457) sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) is a organic sodium salt (CHEBI:38700) IUPAC Name sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate Synonyms Sources SSR ChEBI SSR128129E ChEBI Registry Number Type Source 11430504 Reaxys Registry Number Reaxys Citations Types Sources 22683470 PubMed citation Europe PMC 23597562 PubMed citation SUBMITTER 23597563 PubMed citation Europe PMC Last Modified 03 May 2013